maximizing Oncology analysis with Integrated KRAS Assay solutions and RAS Assays
In the swiftly evolving subject of oncology research, exact and efficient mutation screening is critical for creating targeted therapies. The KRAS companies Platform plays a pivotal purpose On this landscape by presenting complete answers for KRAS mutation profiling and Investigation. KRAS mutations, present in approximately 95% of RAS-associated o